NBIX

Neurocrine Biosciences, Inc.

Healthcare›Drug Manufacturers - Specialty & Generic|NASDAQ Global Select|US

Price

$131.60

Market Cap

$13.21B

Beta

0.36

P/E

28.1

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+21.45%

EPS Growth (YoY)+41.64%

Revenue CAGR 3Y+24.32%

P/E Ratio28.1

PEG Ratio0.68

FCF Yield+5.67%

Debt / Equity0.13

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for NBIX.